Antibacterial therapy is the foundation of community acquired pneumonia (CAP). Accordingly, treatment options >> << impact likely etiology, local features of pathogen resistance, and patient factors. Since the main reason >> << severe CAP, susceptibility models
pneumococcus greatly influenced antimicrobial and dosage recommended for empirical treatment of this disease. Worldwide >> << emergence of community acquired methicillin-resistant gold
Staphylococcus also led to a discussion of this pathogen in the recent changes strattera no prescritpion in international guidelines for CAP. This pathogen is an important >> << thanks to its resistance to antibiotics commonly recommended for empirical treatment of CAP and association with
rapidly lethal form of pneumonia characterized by tissue necrosis, pulmonary hemorrhage, and rapid progression of respiratory failure
. In tropical regions of Asia and Australia, due to the CAP
Acinetobacter baumannii is also becoming more widely recognized. In this review discusses their recent epidemiology, microbiology, clinical features and treatment
VP caused by these resistant to antimicrobial agents. .
No comments:
Post a Comment